| Literature DB >> 32953741 |
Haobin Zhang1, Si Qin2,3, Lei Zhang4, Zhuxiao Feng5, Changhe Fan5.
Abstract
BACKGROUND: This study investigated the depression, anxiety, and insomnia levels of coronavirus disease 2019 (COVID-19) patients admitted to two mobile cabin hospitals in Jianghan District (Wuhan, China).Entities:
Keywords: Coronavirus disease 2019 (COVID-19); anxiety; depression; insomnia; mobile cabin hospital; patient psychology; patient-centered care
Year: 2020 PMID: 32953741 PMCID: PMC7475439 DOI: 10.21037/atm-20-4907
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Details of assessments for depression, anxiety, and insomnia
| Variable | Assessment scale | Details | Scoring |
|---|---|---|---|
| Depression | PHQ-9 | Participants were asked to rate how often they were bothered by the described symptoms (i.e., the 9 DSM-IV criteria) over the past 2 weeks using a 4-point rating scale, ranging from 0 (“ | Total scores ranging from 0 to 27, in which scores of between 0 and 4 represent an absence of depression, while scores of 5–9, 10–14, 15–19, and 20–27 indicate mild, moderate, moderately severe, and severe depression, respectively |
| Anxiety | GAD-7 | Participants were asked to rate how often they were bothered by the described symptoms (i.e., 7 common anxiety symptoms) over the past 2 weeks using a 4-point rating scale, ranging from 0 (“ | Total scores ranging from 0 to 21, in which scores of between 0 and 4 represent an absence of anxiety, while scores of 5–9, 10–14, and 15–21 indicate mild, moderate, and severe anxiety, respectively |
| Insomnia | ISI | Participants responded to items with reference to a 6-point rating scale, with scores ranging from 0 to 4 (0= “ | Total scores ranging from 0 to 28, in which a score between 0 and 7 represents no clinically significant insomnia, while scores of 8–14, 15–21, and 22–28 indicate mild, moderately clinical, and severe insomnia, respectively |
DSM-IV, Diagnostic and Statistical Manual for Mental Disorders (4th ed.); GAD-7, Generalized Anxiety Disorder 7; ISI, Insomnia Severity Index; PHQ-9, Patient Health Questionaire-9.
Sociodemographic and clinical characteristics of the COVID-19 patients in the study
| Characters | Outcome |
|---|---|
| Age (years)b | |
| <30 | 4 (13.33) |
| 30–39 | 9 (30.0) |
| 40–49 | 6 (20.0) |
| 50–59 | 9 (30.0) |
| >60 | 2 (6.67) |
| Occupation (medical-related work)b | |
| Yes | 1 (3.33) |
| No | 29 (96.67) |
| Sexb | |
| Male | 15 (50.0) |
| Female | 15 (50.0) |
| Religionb | |
| Yes | 1 (3.33) |
| No | 29 (96.67) |
| Locationb | |
| Local | 29 (96.67) |
| Non-local | 1 (3.33) |
| Marriage statusb | |
| Married | 24 (80.0) |
| Unmarried | 6 (20.0) |
| COVID-19 typeb | |
| Mild | 8 (26.67) |
| Common | 22 (73.33) |
| Medical historyb | |
| High blood pressure | 1 (3.33) |
| Pregnancy-induced hypertension syndrome | 1 (3.33) |
| Eczema | 1 (3.33) |
| None | 27 (90.0) |
b, n (%). COVID-19, coronavirus disease 2019.
Comparison of anxiety, depression, and insomnia scores of participants following admission to the mobile cabin hospitals
| Variable | n | Anxiety | Depression | Insomnia | |||||
|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | t-statistic, P value | Mean ± SD | t-statistic, P value | Mean ± SD | t-statistic, P value | ||||
| Sex | t=−0.267, P=0.792 | t=0.708, P=0.485 | P=0.486 | ||||||
| Female | 15 | 10.27±1.580 | 11.20±2.077 | 8.73±2.052 | |||||
| Male | 15 | 10.40±1.121 | 10.73±1.486 | 8.13±1.552 | |||||
| Type | P<0.001 | P<0.001 | P<0.202 | ||||||
| Mild | 8 | 9±0.756 | 8.88±0.991 | 7.75±1.488 | |||||
| Common | 22 | 10.82±1.181 | 11.73±1.352 | 8.68±1.887 | |||||
Figure 1COVID-19 patients with various degrees of anxiety, depression, and insomnia in the mobile cabin hospitals. COVID-19, coronavirus disease 2019.
Comparison of the scores from two evaluations of the study’s COVID-19 patients
| Variable | First evaluation | Second evaluation | t-statistic, P value |
|---|---|---|---|
| Anxiety scoresa | 10.33±1.348 | 3.17±1.533 | P<0.001 |
| Depression scoresa | 10.97±1.790 | 3.53±0.860 | P<0.001 |
| Insomnia scoresa | 8.43±1.813 | 7.63±1.129 | t=2.202, P=0.036 |
a, mean ± SD. COVID-19, coronavirus disease 2019.
Improvement of depression, anxiety, and insomnia symptoms in the study’s COVID-19 patients
| Variable | Patients (n) | Significant improvement (%) | Improvement (%) | Non-improvement (%) |
|---|---|---|---|---|
| Anxiety | 30 | 63.3 (n=19) | 36.7 (n=11) | 0 (n=0) |
| Depression | 30 | 63.3 (n=19) | 36.7 (n=11) | 0 (n=0) |
| Insomnia | 22 | 0 (n=0) | 50 (n=11) | 50 (n=11) |
COVID-19, coronavirus disease 2019.
Figure 2Causes of psychological changes of patients after treatment in the mobile cabin hospitals.